Literature DB >> 28222443

ENETS Consensus Recommendations for the Standards of Care in Neuroendocrine Neoplasms: Follow-Up and Documentation.

U Knigge1, J Capdevila, D K Bartsch, E Baudin, J Falkerby, R Kianmanesh, B Kos-Kudla, B Niederle, E Nieveen van Dijkum, D O'Toole, A Pascher, N Reed, A Sundin, M-P Vullierme.   

Abstract

Entities:  

Year:  2017        PMID： 28222443     DOI： 10.1159/000458155

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN： 0028-3835            Impact factor:   4.914


× No keyword cloud information.
  22 in total

1.  The prognosis and management of neuroendocrine neoplasms-related metastatic bone disease: lessons from clinical practice.

Authors:  Krystallenia I Alexandraki; Michail Pizanias; Inbal Uri; Dimitrios Thomas; Tristan Page; Denise Kolomodi; Chen Sheng Low; Olu Adesanya; Marina Tsoli; David J Gross; Harpal Randeva; Rajaventhan Srirajaskanthan; Simona Grozinsky-Glasberg; Gregory Kaltsas; Martin O Weickert
Journal:  Endocrine       Date:  2019-01-11       Impact factor: 3.633

2.  Neuroendocrine neoplasms - still a challenge despite major advances in clinical care with the development of specialized guidelines.

Authors:  Stephan Petersenn; Christian A Koch
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

Review 3.  Hormone secreting gastro-entero-pancreatic neuroendocrine neoplasias (GEP-NEN): When to consider, how to diagnose?

Authors:  Christian Fottner; Martina Ferrata; Matthias M Weber
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

4.  Clinical Management of Neuroendocrine Neoplasms in Clinical Practice: A Formal Consensus Exercise.

Authors:  Mirco Bartolomei; Alfredo Berruti; Massimo Falconi; Nicola Fazio; Diego Ferone; Secondo Lastoria; Giovanni Pappagallo; Ettore Seregni; Annibale Versari
Journal:  Cancers (Basel)       Date:  2022-05-19       Impact factor: 6.575

Review 5.  Malignant insulinoma: Can we predict the long-term outcomes?

Authors:  Maja Cigrovski Berkovic; Monika Ulamec; Sonja Marinovic; Ivan Balen; Anna Mrzljak
Journal:  World J Clin Cases       Date:  2022-06-06       Impact factor: 1.534

6.  Prognostic Utility of 24-Hour Urinary 5-HIAA Doubling Time in Patients With Neuroendocrine Tumors.

Authors:  Amit Tirosh; Naris Nilubol; Dhaval Patel; Electron Kebebew
Journal:  Endocr Pract       Date:  2018-08-07       Impact factor: 3.443

Review 7.  [Pulmonary carcinoids and carcinoids of the small intestine].

Authors:  K S Winter; C J Auernhammer; A Todica; J Ricke; C Cyran
Journal:  Radiologe       Date:  2019-11       Impact factor: 0.635

Review 8.  [Neuroendocrine tumors of the stomach, duodenum and pancreas : Value of (hybrid) radiological diagnostics].

Authors:  J Rübenthaler; C Auernhammer; I Harun; J Ricke; C C Cyran
Journal:  Radiologe       Date:  2019-11       Impact factor: 0.635

9.  Recurrence Patterns After Surgical Resection of Gastroenteropancreatic Neuroendocrine Tumors: Analysis From the National Comprehensive Cancer Network Oncology Outcomes Database.

Authors:  Hilary Chan; Li Zhang; Michael A Choti; Matthew Kulke; James C Yao; Eric K Nakakura; Mark Bloomston; Al B Benson; Manisha H Shah; Jonathan R Strosberg; Emily K Bergsland; Katherine Van Loon
Journal:  Pancreas       Date:  2021-04-01       Impact factor: 3.243

10.  Semiautomatic Tumor Delineation for Evaluation of 64Cu-DOTATATE PET/CT in Patients with Neuroendocrine Neoplasms: Prognostication Based on Lowest Lesion Uptake and Total Tumor Volume.

Authors:  Esben Andreas Carlsen; Camilla Bardram Johnbeck; Mathias Loft; Andreas Pfeifer; Peter Oturai; Seppo W Langer; Ulrich Knigge; Claes Nøhr Ladefoged; Andreas Kjaer
Journal:  J Nucl Med       Date:  2021-02-26       Impact factor: 11.082
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.